The Effect of (-)-Epigallocatechin-3-Gallate on IL-1β Induced IL-8 Expression in Orbital Fibroblast from Patients with Thyroid-Associated Ophthalmopathy.
Orbital fibroblasts have been reported to be an important effector cells for the development of thyroid-associated ophthalmopathy (TAO). Orbital fibroblasts secrete various inflammatory cytokines in response to an inflammatory stimulation, leading to TAO-related tissue swelling. It has also been rep...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4743944?pdf=render |
_version_ | 1811233466530922496 |
---|---|
author | Ji-Young Lee Ji-Sun Paik Mihee Yun Seong-Beom Lee Suk-Woo Yang |
author_facet | Ji-Young Lee Ji-Sun Paik Mihee Yun Seong-Beom Lee Suk-Woo Yang |
author_sort | Ji-Young Lee |
collection | DOAJ |
description | Orbital fibroblasts have been reported to be an important effector cells for the development of thyroid-associated ophthalmopathy (TAO). Orbital fibroblasts secrete various inflammatory cytokines in response to an inflammatory stimulation, leading to TAO-related tissue swelling. It has also been reported that (-)-epigallocatechin-3-gallate (EGCG), a major polyphenolic constituent of green tea, has antioxidant and anti-inflammatory properties. In the current study, we investigated the issue of whether or how EGCG affects the interleukin (IL)-1β-induced secretion of IL-8 in human orbital fibroblasts from TAO patients. Treatment with EGCG significantly reduced the level of IL-1β-induced secretion of IL-8 and the expression of IL-8 mRNA. IL-1β-induced the degradation of IκBα, and the phosphorylation of p38 and ERK, and the IL-1β-induced expression of IL-8 mRNA was inhibited by specific inhibitors, such as BAY-117085 for NF-kB, SB203580 for p38, and PD98059 for ERK. In addition, treatment with EGCG inhibited the IL-1β-induced degradation of IκBα, and the phosphorylation of p38 and ERK. However, pre-treatment with antioxidants, NVN and NAC, which suppressed ROS generation, did not reduce IL-8 expression in IL-1β-treated orbital fibroblasts, suggesting that the IL-1β-induced IL-8 expression is not mediated by the generation of ROS. These results show that EGCG suppresses the IL-1β-induced expression of IL-8 through inhibition of the NF-κB, p38, and ERK pathways. These findings could contribute to the development of new types of EGCG-containing pharmacological agents for use in the treatment of TAO. |
first_indexed | 2024-04-12T11:20:35Z |
format | Article |
id | doaj.art-e936043928254a82988925ed96c06e25 |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-04-12T11:20:35Z |
publishDate | 2016-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-e936043928254a82988925ed96c06e252022-12-22T03:35:23ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01112e014864510.1371/journal.pone.0148645The Effect of (-)-Epigallocatechin-3-Gallate on IL-1β Induced IL-8 Expression in Orbital Fibroblast from Patients with Thyroid-Associated Ophthalmopathy.Ji-Young LeeJi-Sun PaikMihee YunSeong-Beom LeeSuk-Woo YangOrbital fibroblasts have been reported to be an important effector cells for the development of thyroid-associated ophthalmopathy (TAO). Orbital fibroblasts secrete various inflammatory cytokines in response to an inflammatory stimulation, leading to TAO-related tissue swelling. It has also been reported that (-)-epigallocatechin-3-gallate (EGCG), a major polyphenolic constituent of green tea, has antioxidant and anti-inflammatory properties. In the current study, we investigated the issue of whether or how EGCG affects the interleukin (IL)-1β-induced secretion of IL-8 in human orbital fibroblasts from TAO patients. Treatment with EGCG significantly reduced the level of IL-1β-induced secretion of IL-8 and the expression of IL-8 mRNA. IL-1β-induced the degradation of IκBα, and the phosphorylation of p38 and ERK, and the IL-1β-induced expression of IL-8 mRNA was inhibited by specific inhibitors, such as BAY-117085 for NF-kB, SB203580 for p38, and PD98059 for ERK. In addition, treatment with EGCG inhibited the IL-1β-induced degradation of IκBα, and the phosphorylation of p38 and ERK. However, pre-treatment with antioxidants, NVN and NAC, which suppressed ROS generation, did not reduce IL-8 expression in IL-1β-treated orbital fibroblasts, suggesting that the IL-1β-induced IL-8 expression is not mediated by the generation of ROS. These results show that EGCG suppresses the IL-1β-induced expression of IL-8 through inhibition of the NF-κB, p38, and ERK pathways. These findings could contribute to the development of new types of EGCG-containing pharmacological agents for use in the treatment of TAO.http://europepmc.org/articles/PMC4743944?pdf=render |
spellingShingle | Ji-Young Lee Ji-Sun Paik Mihee Yun Seong-Beom Lee Suk-Woo Yang The Effect of (-)-Epigallocatechin-3-Gallate on IL-1β Induced IL-8 Expression in Orbital Fibroblast from Patients with Thyroid-Associated Ophthalmopathy. PLoS ONE |
title | The Effect of (-)-Epigallocatechin-3-Gallate on IL-1β Induced IL-8 Expression in Orbital Fibroblast from Patients with Thyroid-Associated Ophthalmopathy. |
title_full | The Effect of (-)-Epigallocatechin-3-Gallate on IL-1β Induced IL-8 Expression in Orbital Fibroblast from Patients with Thyroid-Associated Ophthalmopathy. |
title_fullStr | The Effect of (-)-Epigallocatechin-3-Gallate on IL-1β Induced IL-8 Expression in Orbital Fibroblast from Patients with Thyroid-Associated Ophthalmopathy. |
title_full_unstemmed | The Effect of (-)-Epigallocatechin-3-Gallate on IL-1β Induced IL-8 Expression in Orbital Fibroblast from Patients with Thyroid-Associated Ophthalmopathy. |
title_short | The Effect of (-)-Epigallocatechin-3-Gallate on IL-1β Induced IL-8 Expression in Orbital Fibroblast from Patients with Thyroid-Associated Ophthalmopathy. |
title_sort | effect of epigallocatechin 3 gallate on il 1β induced il 8 expression in orbital fibroblast from patients with thyroid associated ophthalmopathy |
url | http://europepmc.org/articles/PMC4743944?pdf=render |
work_keys_str_mv | AT jiyounglee theeffectofepigallocatechin3gallateonil1binducedil8expressioninorbitalfibroblastfrompatientswiththyroidassociatedophthalmopathy AT jisunpaik theeffectofepigallocatechin3gallateonil1binducedil8expressioninorbitalfibroblastfrompatientswiththyroidassociatedophthalmopathy AT miheeyun theeffectofepigallocatechin3gallateonil1binducedil8expressioninorbitalfibroblastfrompatientswiththyroidassociatedophthalmopathy AT seongbeomlee theeffectofepigallocatechin3gallateonil1binducedil8expressioninorbitalfibroblastfrompatientswiththyroidassociatedophthalmopathy AT sukwooyang theeffectofepigallocatechin3gallateonil1binducedil8expressioninorbitalfibroblastfrompatientswiththyroidassociatedophthalmopathy AT jiyounglee effectofepigallocatechin3gallateonil1binducedil8expressioninorbitalfibroblastfrompatientswiththyroidassociatedophthalmopathy AT jisunpaik effectofepigallocatechin3gallateonil1binducedil8expressioninorbitalfibroblastfrompatientswiththyroidassociatedophthalmopathy AT miheeyun effectofepigallocatechin3gallateonil1binducedil8expressioninorbitalfibroblastfrompatientswiththyroidassociatedophthalmopathy AT seongbeomlee effectofepigallocatechin3gallateonil1binducedil8expressioninorbitalfibroblastfrompatientswiththyroidassociatedophthalmopathy AT sukwooyang effectofepigallocatechin3gallateonil1binducedil8expressioninorbitalfibroblastfrompatientswiththyroidassociatedophthalmopathy |